Drug Evaluation Committee FY2024 Assembly of the Clinical Evaluation Subcommittee, Part 2: "What Will Happen? What to do? Clinical Research and Clinical Trials in Japan -Promoting Clinical Research and Clinical Trials based on High Drug Discovery Capability and Strong International Competitiveness-".
Mar 24, 2025
At the Assembly of the Clinical Evaluation Committee held on February 14, 2025, the first part of the meeting featured a report on the Committee's activities, and the second part featured lectures and a panel discussion on the changing environment and future direction for the promotion of clinical research and clinical trials.
The following four lecture materials from Part 2 are now available.
- 20250214_What Will Happen? What to do? Clinical Research and Clinical Trials in Japan
- 20250214_Expectations for Future Directions in Promoting Clinical Research and Clinical Trials: Based on the Current Status and Issues in Academia
- 20250214_Promotion of Clinical Research and Clinical Trials: Toward Strong International Competitiveness
- 20250214_Future Directions for the Promotion of Clinical Research and Clinical Trials